Linaldo Vilar - Diagnsticos Director of Production
| DASA3 Stock | BRL 4.70 0.01 0.21% |
Director
Mr. Linaldo Vilar, Jr. serves as the Director of Production of Diagnosticos da America S.A. since July 25, 2016. He has 25 years of experience in the supply chain areas of companies such as Kenner, Giroflexforma, CocaCola, Reckitt Benckiser and ABlnBev. He has a degree in Chemical Engineering from the Universidade Catolica De Pernambuco with an Executive MBA from the Business School of So Paulo. He holds Green Belt from the Fundao Christiano Otonni. Has a Supply Chain Leadership Program from Georgia Tech University USA. since 2016.
| Age | 46 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Phone | 55 11 4197 5500 |
| Web | https://www.dasa3.com.br |
Diagnsticos Management Efficiency
The company has return on total asset (ROA) of 0.0224 % which means that it generated a profit of $0.0224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0458) %, meaning that it generated substantial loss on money invested by shareholders. Diagnsticos' management efficiency ratios could be used to measure how well Diagnsticos manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Guilherme Laager | M Dias Branco | 60 | |
| Francisco Maia | M Dias Branco | 58 | |
| Pedro Cerize | Porto Seguro SA | 48 | |
| Walter Janssen | Grendene SA | 59 | |
| Maria Branco | M Dias Branco | 83 | |
| Ricardo Weiss | M Dias Branco | 58 | |
| Bruno Garfinkel | Porto Seguro SA | 40 | |
| Oswaldo Assis | Grendene SA | 65 | |
| Caio David | Porto Seguro SA | 45 | |
| Affonso Pastore | M Dias Branco | 78 | |
| Fernando Iunes | M Dias Branco | 50 | |
| Fernando Lottenberg | Porto Seguro SA | 55 | |
| Evandro Coura | Porto Seguro SA | 56 | |
| Lucia Hauptmann | Porto Seguro SA | 50 | |
| Renato Ochman | Grendene SA | 55 | |
| Marcio Schettini | Porto Seguro SA | 53 | |
| Mailson Nobrega | Grendene SA | 73 | |
Management Performance
| Return On Equity | -0.0458 | |||
| Return On Asset | 0.0224 |
Diagnsticos da Amrica Leadership Team
Elected by the shareholders, the Diagnsticos' board of directors comprises two types of representatives: Diagnsticos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagnsticos. The board's role is to monitor Diagnsticos' management team and ensure that shareholders' interests are well served. Diagnsticos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagnsticos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ricardo Orlando, Chief Information Technology | ||
| Fabio Cunha, Chief Legal & Compliance Officer | ||
| Pedro Bueno, Chief Executive Officer, Director | ||
| Ricardo SIlva, Private and Hospitals Businesses Officer | ||
| Oscar Bernardes, Independent Vice Chairman of the Board | ||
| Carlos Neto, Chief Director | ||
| Romeu Domingues, Chairman of the Board | ||
| Carlos Aquino, Accounting and Infrastructure Officer, Member of the Executive Board | ||
| Carlos Jorge, Chief Administrative and Finance Officer, Investor Relations Officer | ||
| Adriano Lima, Executive Vice President of Human Resources | ||
| Leonardo Vedolin, Director of RDI | ||
| Fbio Cunha, Chief Officer | ||
| Lilian Lira, Legal Officer, Member of the Executive Board | ||
| Octavio Silva, Member of the Executive Board, Vice President of Operations | ||
| Emerson Gasparetto, Radiology and Graphic Methods Officer, Member of the Executive Board | ||
| Marcelo Barboza, Director | ||
| Paulo CattaPreta, Member of the Executive Board | ||
| Alexandre Barros, Independent Director | ||
| Linaldo Vilar, Director of Production | ||
| Henrique Jager, Independent Director | ||
| Gustavo Campana, Medical Director of Clinical Analysis | ||
| Linaldo Junior, Chief Officer | ||
| Antonio Gaeta, Member of the Executive Board, Executive Vice President of Business | ||
| Felipe Guimaraes, Chief Officer |
Diagnsticos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Diagnsticos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0458 | |||
| Return On Asset | 0.0224 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 17.24 B | |||
| Shares Outstanding | 557.11 M | |||
| Shares Owned By Insiders | 56.27 % | |||
| Shares Owned By Institutions | 33.62 % | |||
| Price To Earning | 63.21 X | |||
| Price To Book | 1.00 X |
Pair Trading with Diagnsticos
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diagnsticos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diagnsticos will appreciate offsetting losses from the drop in the long position's value.Moving together with Diagnsticos Stock
| 0.86 | ACNB34 | Accenture plc | PairCorr |
Moving against Diagnsticos Stock
| 0.82 | AMZO34 | Amazon Inc | PairCorr |
| 0.73 | JDCO34 | JD Inc | PairCorr |
| 0.73 | BERK34 | Berkshire Hathaway | PairCorr |
| 0.71 | WALM34 | Walmart Split | PairCorr |
| 0.69 | TGTB34 | Target | PairCorr |
The ability to find closely correlated positions to Diagnsticos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Diagnsticos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Diagnsticos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Diagnsticos da Amrica to buy it.
The correlation of Diagnsticos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Diagnsticos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Diagnsticos da Amrica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Diagnsticos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Diagnsticos da Amrica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Diagnsticos da Amrica information on this page should be used as a complementary analysis to other Diagnsticos' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Diagnsticos Stock analysis
When running Diagnsticos' price analysis, check to measure Diagnsticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnsticos is operating at the current time. Most of Diagnsticos' value examination focuses on studying past and present price action to predict the probability of Diagnsticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnsticos' price. Additionally, you may evaluate how the addition of Diagnsticos to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |